Researchers from Rice University and Baylor College of Medicine have demonstrated a groundbreaking treatment that eradicates ...

Innovent Biologics has made the case that its checkpoint inhibitor-cytokine fusion protein has a future in colorectal cancer.

GlobalData’s report assesses the drugs in the Interleukin 2 pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.

Analyst Judah Frommer from Morgan Stanley maintained a Buy rating on Mural Oncology Plc (MURA – Research Report) and keeping the price ...

Cytokines enable communication between immune cells, encouraging their proliferation, differentiation, and functional activation. For example, interleukin-2 (IL-2) improves T cell proliferation and ...

Vivtex to apply its GI-ORIS™ technology to optimize oral bioavailability of EQ302, Equillium’s novel IL-15/IL-21 bi-specific peptide ...

BOSTON, Sept. 03, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class ...

Rice University and Baylor College of Medicine have received $2.8 million in funding from the National Heart, Lung, and Blood ...

Depemokimab was shown to reduce exacerbations in patients with severe asthma. The proportions of adverse events of ...

Researchers assess the airway microbiome and host immune-inflammatory responses to identify treatable aspects of severe ...